Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia

Lookup NU author(s): Dr Ashleigh Herriott, Dr Susan Tudhope, Gesa Junge, Natalie Rodrigues, Dr Miranda MortonORCiD, Dr Laura Woodhouse, Emeritus Professor John LunecORCiD, Dr Jill Hunter, Dr Evan Mulligan, Mike ColeORCiD, Dr Jonathan Wallis, Professor Nicola CurtinORCiD, Dr Elaine WillmoreORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Herriott A, Tudhope SJ, Junge G, Rodrigues N, Patternson MJ, Woodhouse L, Lunec J, Hunter JE, Mulligan EA, Cole M, Allinson LM, Wallis JP, Marshall S, Wang E, Curtin NJ, Willmore E

Publication type: Article

Publication status: Published

Journal: Oncotarget

Year: 2015

Volume: 6

Issue: 41

Pages: 43978-43991

Online publication date: 02/11/2015

Acceptance date: 10/10/2015

Date deposited: 18/11/2015

ISSN (electronic): 1949-2553

Publisher: Impact Journals, LLC

URL: http://dx.doi.org/10.18632/oncotarget.6287

DOI: 10.18632/oncotarget.6287

PubMed id: 26539646

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
Tyneside Leukaemia Research Association (now part of Newcastle Healthcare Charity)
Medical Research Council/AstraZeneca
10035Leukaemia & Lymphoma Research
13034Leukaemia & Lymphoma Research
C7369/A8048Cancer Research UK
KKL409Kay Kendall Leukaemia Fund
10035Bloodwise (Formerly Leukaemia and Lymphoma Research)

Share